《Scientific Reports》11月16日论文:120例对120例对照中MMP9 rs17576的G等位基因频率52.5%对41.2%,与乳腺癌易感性相关

沙特阿拉伯塔布克大学与埃及多家机构的联合团队在《Scientific Reports》发表论文,11月16日刊出,通讯作者为 Rami M. Elshazli。基质金属蛋白酶9(MMP9)参与细胞外基质重塑,此前已被认为与包括乳腺癌在内的多种癌症的侵袭与转移有关;这项研究检验 MMP9 的两个变异 rs17576 与 rs3787268 是否与乳腺癌易感性相关。
研究采用病例对照设计,纳入120名乳腺癌患者与120名年龄匹配的健康对照,用 TaqMan 等位基因鉴别法做基因分型,再用逻辑回归评估基因型、等位基因与单倍型层面的关联,并辅以 GEPIA2、GTEx、TNMplot、muTarget、STRING、I-Mutant 与 3DSNP 等生物信息学分析,考察表达模式、表达数量性状位点效应与蛋白稳定性。
错义变异 rs17576 在多个遗传模型下与乳腺癌易感性显著相关:A/G 基因型的比值比为2.31(95%置信区间1.24至4.29,p值为0.007),G/G 基因型为2.46(95%置信区间1.16至5.22,p值为0.017);患者组 G 等位基因频率为52.5%,对照组为41.2%,比值比1.57(95%置信区间1.10至2.26,p值为0.013)。内含子变异 rs3787268 则没有显示独立关联。生物信息学分析提示 rs17576 可能影响 MMP9 的功能与调控,包括预测的蛋白去稳定化(ΔΔG为负0.34千卡每摩尔)与乳腺组织表达数量性状位点效应,且 MMP9 在乳腺癌组织中表达升高并与疾病进展相关。
作者明确提醒,该研究只在单一埃及女性人群中完成,样本量有限,结果应谨慎解读,需要在更大、更多族群的队列中验证并辅以功能实验。本文只报道研究数据,不构成对任何个人做基因检测或就医的建议。
图中是一名女性正在接受乳腺X线摄影检查,乳腺癌的早期发现与风险研究是这篇易感性论文的临床背景。
Scientific Reports Paper, November 16: in 120 Cases and 120 Controls, the G Allele of MMP9 rs17576 Was Found in 52.5 Percent Versus 41.2 Percent and Was Associated With Breast Cancer Susceptibility
A joint team from the University of Tabuk in Saudi Arabia and several Egyptian institutions has published a paper in Scientific Reports on November 16, with Rami M. Elshazli as corresponding author. Matrix metalloproteinase-9 (MMP9) takes part in extracellular matrix remodeling and has been implicated in tumor invasion and metastasis in several cancers, including breast cancer; the study tested whether two MMP9 variants, rs17576 and rs3787268, are associated with breast cancer susceptibility.
The case-control study enrolled 120 breast cancer patients and 120 age-matched healthy controls. Genotyping used TaqMan allelic discrimination assays, logistic regression models evaluated genotype, allele and haplotype associations, and complementary bioinformatic analyses with GEPIA2, GTEx, TNMplot, muTarget, STRING, I-Mutant and 3DSNP examined expression patterns, expression quantitative trait locus effects and protein stability.
The missense variant rs17576 was significantly associated with breast cancer susceptibility under several genetic models: an odds ratio of 2.31 (95% CI, 1.24 to 4.29; p = 0.007) for the A/G genotype and 2.46 (95% CI, 1.16 to 5.22; p = 0.017) for G/G. The G allele frequency was 52.5 percent in patients versus 41.2 percent in controls (odds ratio 1.57; 95% CI, 1.10 to 2.26; p = 0.013). The intronic variant rs3787268 showed no independent association. Bioinformatic analyses suggested rs17576 may influence MMP9 function and regulation, including predicted protein destabilization (ΔΔG of −0.34 kcal/mol) and breast-tissue expression quantitative trait locus effects, alongside increased MMP9 expression in breast cancer tissues and an association with disease progression.
The authors caution that the single-population design in Egyptian women and the modest sample size mean the results should be interpreted cautiously and require validation in larger, ethnically diverse cohorts together with functional investigations. This report presents the study data only and offers no advice on genetic testing or care for any individual.
发布:GSM·美国(发布链接)
图片来源:Wikimedia Commons, File:Mammogram.jpg — Author: National Cancer Institute. Licensing: Public domain.
GSM Global · 本篇英文版 English edition of this story

